![](https://d3ilqtpdwi981i.cloudfront.net/8UJ-g2caX0bJ77nUwwyVzsdQOc4=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/1e/78/ec/1e78ec4d-8292-4e0b-812e-f1c8a290e2da/thumbnail_6c31cd79-8e61-41c4-a0a7-0c940f4f3320.jpg)
Short-circuit current (I sc) and transepithelial conductance (G t) were measured in guinea pig distal colonic mucosa isolated from submucosa and underlying muscle layers. Indomethacin (2 μM) and NS-398 (2 μM) were added to suppress endogenous production of prostanoids. Serosal addition of PGE2 (10 nM) stimulated negative I scconsistent with K secretion, and concentrations >30 nM stimulated positive I sc consistent with Cl secretion. PGE2 also stimulated G t at low and high concentrations. Dose responses to prostanoids specific for EP prostanoid receptors were consistent with stimulating K secretion through EP2receptors, based on a rank order potency (from EC50 values) of PGE2 (1.9 nM) > 11-deoxy-PGE1 (8.3 nM) > 19(R)-hydroxy-PGE2 (13.9 nM) > butaprost (67 nM) > 17-phenyl-trinor-PGE2 (307 nM) ≫ sulprostone (>10 μM). An isoprostane, 8-iso-PGE2, stimulated K secretion with an EC50 of 33 nM. Cl secretory response was stimulated by PGD2 and BW-245C, a DP prostanoid receptor-specific agonist: BW-245C (15 nM) > PGD2 (30 nM) > PGE2 (203 nM). Agonists specific for FP, IP, and TP prostanoid receptors were ineffective in stimulating I sc and G t at concentrations <1 >μM. These results indicate that PGE2stimulated electrogenic K secretion through activation of EP2 receptors and electrogenic KCl secretion through activation of DP receptors. Thus stimulation of Cl secretion in vivo would occur either via physiological concentrations of PGD2(<100 >nM) or pathophysiological concentrations of PGE2(>100 nM) that could occur during inflammatory conditions.
Available at: http://works.bepress.com/dan_halm/21/